Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (15968)	8/14/2002 12:36:59 AM
From: aknahow	Respond to of 17367

Larry, if a company has thousands of employees I would expect that any infiltrators would actually have the indication being treated. Those enrolled in a competitor's trial might be led to believe that they were doing nothing wrong. They would be grateful that their company had helped them get in the trial. Normal follow up, as simple as asking how the trial is going and asking to share any documents the person signed off on. By repeatedly asking how the subjects were feeling and wondering out loud if that was a side effect would make the employee more apt to emphasize side effects with the doctors running the trial. The above applies to honest employees. There will always be some that for a price would work with pleasure to help their own company in any way they could.